Determining the impact of opioid substitution therapy upon mortality and recidivism among prisoners: A 22-year data linkage study

Funding Activity

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

This study will quantify the impact of opioid substitution therapy (OST; methadone or buprenorphine) on two important outcomes for opioid dependent prisoners: mortality, particularly in the post-release period; and subsequent criminal activity. The study will have almost 600,000 person-years of follow-up over 22 years, allowing fine grained analyses of disadvantaged subpopulations. The study has clear implications for the health of this population, crime reductions, and cost savings.

Funded Activity Details

Start Date: 01-01-2011

End Date: 01-01-2014

Funding Scheme: Project Grants

Funding Amount: $354,114.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Public Health and Health Services not elsewhere classified

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

Aboriginal health | buprenorphine | criminality | methadone substitution programs | mortality | opioid dependence